SCOPUS 정보 검색 플랫폼

Aging Clinical and Experimental Research

Volumn 13, Issue 2, 2001, Pages 112-121

A multicenter, randomized, controlled trial to evaluate the safety profile, tolerability, and efficacy of rofecoxib in advanced elderly patients with osteoarthritis

(8) Truitt, K E a Sperling, R S a Ettinger, W H b Greenwald, M c DeTora, L a Zeng, Q a Bolognese, J a Ehrich, E a

a MERCK RESEARCH LABORATORIES (United States)

b Virtua Health (United States)

c NONE (United States)

Author keywords

Advanced elderly; COX 2 inhibitors; Osteoarthritis; Safety

Indexed keywords

ACETYLSALICYLIC ACID; ALPHA TOCOPHEROL; ANTACID AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; CYCLOOXYGENASE 2 INHIBITOR; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; NABUMETONE; NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL; PLACEBO; ROFECOXIB;

AGED; ARTICLE; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIGESTIVE SYSTEM ULCER; DISABILITY; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; EDEMA; FEMALE; FLUID RETENTION; HUMAN; HYPERTENSION; KIDNEY DISEASE; LEG EDEMA; MAJOR CLINICAL STUDY; MALE; MORNING STIFFNESS; MULTICENTER STUDY; OSTEOARTHRITIS; PAIN; PAIN ASSESSMENT; RANDOMIZED CONTROLLED TRIAL; RATING SCALE;

AGED; AGED, 80 AND OVER; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BUTANONES; DISABILITY EVALUATION; FEMALE; HUMANS; LACTONES; MALE; OSTEOARTHRITIS; PAIN MEASUREMENT; SULFONES; TREATMENT OUTCOME;

EID: 0034992974 PISSN: 03949532 EISSN: None Source Type: Journal
DOI: 10.1007/bf03351533 Document Type: Article

Times cited : (72)

References (30)

1
- 0028608738
- Rheumatoid arthritis and osteoarthritis. Current and future therapies
- (1994) Am. Pharm , vol.34 NS , pp. 31-42
- Flynn, B.¹

2
- 0021873306
- Utilization of non steroidal antiinflammatory drugs
- (1985) Arthritis Rheum , vol.28 , pp. 686-692
- Baum, C.¹ Kennedy, D.L.² Forbes, M.B.³

3
- 0025143782
- Nonsteroidal anti-inflammatory drugs
- (1990) Clin. Geriatr. Med , vol.6 , pp. 365-441
- Murray, M.D.¹ Brater, D.C.²

4
- 0033577982
- Medical progress - Gastrointestinal toxicity of nonsteroidal antiinflammatory drugs
- (1999) N. Engl. J. Med , vol.340 , pp. 1888-1897
- Wolfe, M.M.¹ Lichtenstein, D.R.² Gurkirpal, S.³

5
- 0031058680
- NSAIDs and the elderly: Toxicity and economic implications
- (1997) Drugs and Aging , vol.10 , pp. 119-129
- Phillips, A.C.¹ Polisson, R.P.² Simon, L.S.³

6
- 0034041594
- Rofecoxib, a specific inhibitor of cyclooxygenase 2, with clinical efficacy comparable with that of diclofenac: Results of a one-year, randomized, clinical trial in patients with osteoarthritis of the knee and hip
- for the Rofecoxib Phase III Protocol 035 Study Group
- (2000) Arthritis Rheum , vol.43 , pp. 978-987
- Cannon, G.W.¹ Caldwell, J.R.² Holt, P.³ McLean, B.⁴ Seidenberg, B.⁵ Bolognese, J.⁶ Ehrich, E.⁷ Mukhopadhyay, S.⁸ Daniels, B.⁹

7
- 0034717664
- A Randomized Trial of the Efficacy and Tolerability of the COX-2 Inhibitor Rofecoxib vs Ibuprofen in Patients with Osteoarthritis
- for the Rofecoxib/Ibuprofen Comparator Study Group
- (2000) Arch. Intern. Med , vol.160 , pp. 1781-1787
- Day, R.¹ Morrison, B.² Luza, A.³ Casteneda, O.⁴ Strusberg, A.⁵ Nahir, M.⁶ Helgetveit, K.B.⁷ Kress, B.⁸ Daniels, B.⁹ Bolognese, J.¹⁰ Krupa, D.¹¹ Seidenberg, B.¹² Elliot, E.¹³

8
- 0001175594
- Specific inhibition of cyclooxygenase-2 with MK-0966 is associated with less gastroduodenal damage than either aspirin or ibuprofen. Aliment
- (1999) Pharmacol. Ther , vol.13 , pp. 761-767
- Lanza, F.L.¹ Rack, M.L.² Simon, T.J.³ Quan, H.⁴ Bolognese, J.A.⁵ Hoover, M.E.⁶

9
- 0032851480
- A randomized trial comparing the effect of rofecoxib, a COX-2 specific inhibitor, to ibuprofen on the gastroduodenal mucosa of osteoarthritis patients
- for the Rofecoxib Osteoarthritis Endoscopy Study Group
- (1999) Gastroenterology , vol.117 , pp. 776-783
- Laine, L.¹ Harper, S.² Simon, T.³ Bath, R.⁴ Johanson, J.⁵ Schwartz, H.⁶ Stern, S.⁷ Quan, H.⁸ Bolognese, J.⁹

10
- 0033601079
- Incidence of Upper Gastrointestinal Perforations, Symptomatic Ulcers, Bleeding (PUBs). Rofecoxib Compared to NSAIDs
- (1999) JAMA , vol.282 , pp. 1929-1933
- Langman, M.J.¹ Jensen, D.M.² Watson, D.J.³ Harper, S.E.⁴ Zhao, P.L.⁵ Quan, H.⁶ Bolognese, J.A.⁷ Simaon, T.J.⁸

11
- 0034121667
- Comparison of the effect of rofecoxib (a cyclooxygenase 2 inhibitor), ibuprofen, and placebo on the gastroduodenal mucosa of patients with osteoarthritis. A randomized, controlled, double-blind, placebo-controlled trial
- for the Rofecoxib Osteoarthritis Endoscopy Multinational Study Group
- (2000) Arthritis Rheum , vol.43 , pp. 370-377
- Hawkey, C.¹ Laine, L.² Simon, T.³ Beaulieu, A.⁴ Maldonado-Cocco, J.⁵ Acevedo, E.⁶ Shahane, A.⁷ Quan, H.⁸ Bolognese, J.⁹ Mortensen, E.¹⁰

12
- 0033799852
- COX-2 inhibition with rofecoxib does not increase intestinal permeability in healthy subjects: A double blind crossover study comparing rofecoxib with placebo and indomethacin
- (2000) Gut , vol.47 , pp. 527-532
- Sigthorsson, G.¹ Crane, R.² Simon, T.³ Hoover, M.⁴ Quan, H.⁵ Bolognese, J.⁶ Bjarnason, I.⁷

13
- 0034663376
- A randomized trial measuring fecal blood loss after treatment with rofecoxib, ibuprofen, or placebo in healthy subjects
- (2000) Am. J. Med , vol.109 , pp. 201-206
- Hunt, R.H.¹ Bowen, B.² Mortensen, E.R.³ Simon, T.J.⁴ James, C.⁵ Cagliola, A.⁶ Quan, H.⁷ Bolognese, J.A.⁸

14
- 0034707105
- Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis
- for the VIGOR Study Group
- (2000) N. Engl. J. Med , vol.343 , pp. 1520-1528
- Bombardier, C.¹ Laine, L.² Reicin, A.³ Shapiro, D.⁴ Burgos-Vargas, R.⁵ Davis, B.⁶ Day, R.⁷ Ferraz, M.B.⁸ Hawkey, C.J.⁹ Hochberg, M.C.¹⁰ Kvien, T.K.¹¹ Schnitzer, T.J.¹²

15
- 0016823810
- Mini-Mental State: A practical method for grading the cognitive state of patients for the clinician
- (1975) J. Psychiatr. Res , vol.12 , pp. 189-198
- Folstein, M.F.¹

16
- 0024268463
- Validation study of WOMAC: A health status instrument for measuring clinically important patient relevant outcomes to antirheumatic drug therapy in patients with osteoarthritis of the hip or knee
- (1988) J. Rheumatol , vol.15 , pp. 1833-1840
- Bellamy, N.¹ Buchanan, W.W.² Goldsmith, C.H.³ Campbell, J.⁴ Stitt, L.⁵

17
- 0027912941
- Efficacy and safety of nabumetone versus diclofenac, naproxen, ibuprofen, and piroxicam in the elderly
- (1993) Am. J. Med , vol.95 , pp. 19S-27S
- Morgan, G.J.¹ Poland, M.² DeLapp, R.E.³

18
- 0025635932
- Efficacy and safety of nabumetone in 4,541 elderly patients from a drug monitoring study
- (1990) Drugs , vol.40 , pp. 62-64
- Munzel, P.¹ Lemmel, E.E.²

19
- 0027525061
- A controlled study comparing the effects of nabumetone, ibuprofen, and ibuprofen plus misoprostol on the upper gastrointestinal tract mucosa
- (1993) Arch. Intern. Med , vol.153 , pp. 2565-2571
- Roth, S.H.¹ Tindall, E.A.² Jain, A.K.³ McMahon, G.⁴ April, P.A.⁵ Bockow, B.I.⁶ Cohen, S.B.⁷ Fleishmann, R.M.⁸

20
- 0027404728
- Reporting of age data in clinical trials of arthritis. Deficiencies and solutions
- (1993) Arch. Intern. Med , vol.153 , pp. 243-248
- Rochon, P.A.¹ Fortin, P.R.² Dear, K.B.G.³ Minaker, K.L.⁴ Chalmers, T.C.⁵

21
- 0030796673
- Aging and the musculoskeletal system
- (1997) Ann. Rheum. Dis , vol.56 , pp. 578-585
- Hamerman, D.¹

22
- 0034630270
- Unresolved issues in the role of cyclooxygenase-2 in normal physiologic processes and disease
- (2000) Arch. Intern. Med , vol.160 , pp. 913-920
- Lipsky, P.E.¹ Brooks, P.² Crofford, L.J.³ Du Bois, R.⁴ Graham, D.⁵ Simon, L.S.⁶ van de Putte, L.B.⁷ Abramson, S.B.⁸

23
- 85045784301
- 2and platelet aggregation
- Abstract PII-66
- (1999) Clin. Pharm. Therapeut , vol.65
- Greenberg, H.E.¹ Gillen, L.P.² Dorval, E.P.³ Huntington, M.⁴ Wong, P.⁵ Wildonger, L.⁶ Larson, P.⁷ Gottesdiener, K.M.⁸ Waldman, S.A.⁹

24
- 0025934766
- Nonsteroidal anti-inflammatory drugs: Effects on kidney function
- (1991) J. Clin. Pharmacol , vol.31 , pp. 588-598
- Whelton, A.¹ Hamilton, C.W.²

25
- 0031299946
- NSAIDs and nephrotoxicity in the elderly
- (1997) Geriatr. Nephrol. Urol , vol.7 , pp. 51-57
- Ruiz, J.G.¹ Lowenthal, D.T.²

26
- 0030068309
- Nonsteroidal Anti-inflammatory Drugs and Hypertension - The Risks in Perspective
- (1996) Drugs , vol.51 , pp. 179-187
- de Leeuw, P.W.¹

27
- 0033428385
- Effects of Nonsteroidal Anti-inflammatory Drugs of Renal function: Focus of Cyclooxygenase-2-Selective Inhibition
- (1999) Am. J. Med , vol.107 , pp. 65S-71S
- Brater, D.C.¹

28
- 0028580588
- Do nonsteroidal antiinflammatory drugs affect blood pressure?
- (1994) Ann. Intern. Med , vol.121 , pp. 289-300
- Johnson, A.G.¹ Nguyen, T.V.² Day, R.O.³

29
- 0017198699
- The effect of indomethacin and other anti-inflammatory drugs on the renin-angiotensin system
- (1976) J. Clin. Invest , vol.58 , pp. 282-288
- Romero, J.C.¹ Dunlap, C.L.² Strong, C.G.³

30
- 0025134178
- Nonsteroidal anti-inflammatory drug nephrotoxicity. Should we be concerned?
- (1990) Arch. Intern. Med , vol.150 , pp. 268-270
- Stillman, M.T.¹ Schlesinger, P.A.²

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.